Paper Details

  1. Home
  2. Paper Details

Direct and indirect effects of the 13-valent pneumococcal conjugate vaccine administered to infants and young children.

Author: , EspositoSusanna, PrincipiNicola

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

PCV13 is a 13-valent pneumococcal conjugate vaccine that provides protection against 13 serotypes of pneumococcus. It has been shown to reduce the incidence of invasive pneumococcal disease, community-acquired pneumonia, acute otitis media, rhinosinusitis, and carriage of PCV13 serotypes in both vaccinated and unvaccinated individuals. Further research is needed to determine the effectiveness of PCV13 against certain serotypes and to assess the impact of serotype replacement following its use.
Paper Details　
Original Abstract of the Article :
This paper analyzes the most recent reports regarding the direct and indirect effects of the 13-valent pneumococcal conjugate vaccine (PCV13) when administered to infants and young children. PCV13 extends the protective effects reported for the 7-valent pneumococcal conjugate vaccine (PCV7). A furth...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.2217/fmb.15.81

データ提供：米国国立医学図書館（NLM）

The Impact of 13-Valent Pneumococcal Conjugate Vaccine (PCV13)

This research study takes us on a journey through the realm of immunology, exploring the impact of the 13-valent pneumococcal conjugate vaccine (PCV13) on infants and young children. This vaccine is like a shield against the harsh desert winds of pneumococcal disease, protecting vulnerable young camels. The study explores the direct and indirect effects of PCV13, comparing it to its predecessor, PCV7. This research is like discovering a new oasis in the desert of vaccination research.

A Shield Against the Winds of Disease

The study found that PCV13 extends the protective effects of PCV7 and offers further reduction in the incidence of various pneumococcal diseases. This is a significant finding, as it highlights the progress in protecting young camels from the dangers of these diseases.

Strengthening the Immune System's Defenses

This research reminds us of the importance of vaccines in protecting the health of children. Vaccines are like oases in the desert of disease, providing crucial protection for young camels and safeguarding their well-being.

Dr. Camel's Conclusion

The study sheds light on the ongoing advancements in vaccine technology. PCV13 offers a more comprehensive shield against the harsh realities of pneumococcal disease, paving the way for a healthier and more resilient future for young camels.

Date :
  1. Date Completed 2016-05-17
  2. Date Revised 2022-03-30
Further Info :

Pubmed ID

26439470

DOI: Digital Object Identifier

10.2217/fmb.15.81

Related Literature

Article Analysis
・Effects of pneumococcal conjugate vaccine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.